IPWatchdog

Fresenius Says to Congress, ‘Do as I Say Not as I Do’ on Drug Patents

Congress frequently seeks advice from experts in a wide variety of industries. In theory, this expert testimony helps lawmakers craft better, more nuanced legislation. Sometimes these "expert" witnesses aren't especially knowledgeable. Even worse, sometimes they mislead lawmakers in the hope of advancing legislation that benefits their own companies, even if it hurts the country. That's precisely what happened in June, when the House Judiciary Committee held a hearing to investigate whether pate

بقلم IPWatchdog

1 دقيقة قراءة

هل لديك أخبار لمشاركتها مع صناعة الفعاليات؟

أرسل بياناً صحفياً أو تلميحاً بقصة وتواصل مع آلاف المهنيين في مجال الفعاليات.

تواصل معنا→

المزيد في Intellectual Property Law

رؤى ذات صلة